![Lynette Herscha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lynette Herscha
Directeur des opérations chez
Immunitas Therapeutics, Inc.
Profil
Lynette Herscha is currently the Chief Operating Officer at Immunitas Therapeutics, Inc. She previously worked as the Secretary & General Counsel at Concert Pharmaceuticals, Inc. from 2017 to 2019.
She also held the position of Secretary & Chief Legal Officer at Solid Biosciences, Inc. Ms. Herscha received her undergraduate degree from Boston University and her graduate degree from Boston University School of Law.
Postes actifs de Lynette Herscha
| Sociétés | Poste | Début |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Directeur des opérations | 13/07/2022 |
Anciens postes connus de Lynette Herscha
| Sociétés | Poste | Fin |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2019 |
| SOLID BIOSCIENCES INC. | Conseiller Juridique Général | - |
Formation de Lynette Herscha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
